Hongwei Qi
University of Science and Technology Beijing(CN)
Publications by Year
Research Areas
Cell death mechanisms and regulation, Acute Myeloid Leukemia Research, Genomics, phytochemicals, and oxidative stress, Melanoma and MAPK Pathways, Histone Deacetylase Inhibitors Research
Most-Cited Works
- → Structure of the BTB Domain of Keap1 and Its Interaction with the Triterpenoid Antagonist CDDO(2014)252 cited
- → Dabrafenib; Preclinical Characterization, Increased Efficacy when Combined with Trametinib, while BRAF/MEK Tool Combination Reduced Skin Lesions(2013)213 cited
- → New IDH1 mutant inhibitors for treatment of acute myeloid leukemia(2015)176 cited
- → In vitro and in vivo characterization of a novel soluble epoxide hydrolase inhibitor(2013)110 cited
- → A Tale of Two Subunits: How the Neomorphic R132H IDH1 Mutation Enhances Production of αHG(2011)109 cited
- → Mutant IDH1 Enhances the Production of 2-Hydroxyglutarate Due to Its Kinetic Mechanism(2013)83 cited
- → Prioritizing multiple therapeutic targets in parallel using automated DNA-encoded library screening(2017)74 cited
- → Endocytosis of Epidermal Growth Factor Receptor Regulated by Grb2-mediated Recruitment of the Rab5 GTPase-activating Protein RN-tre(2002)56 cited
- → Long-Range Inhibitor-Induced Conformational Regulation of Human IRE1α Endoribonuclease Activity(2015)54 cited
- → The TRE17 Oncogene Encodes a Component of a Novel Effector Pathway for Rho GTPases Cdc42 and Rac1 and Stimulates Actin Remodeling(2003)53 cited